Total raised
—
Last: Seed 2021-01
Stage
Seed
Founded
2020
Headcount
2
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
Tamarix Pharma is an early-stage biotech company focused on developing novel technologies that restore physiological balance in apoptosis-related diseases.
The company's lead assets are VBIT-4 and VBIT-12, small molecules targeting VDAC1 oligomerization. They were deliberately designed to target a key mitochondrial process known as VDAC1 oligomerization. Their unique mechanism of action represents a highly differentiated approach to potentially treating a variety of acute and chronic conditions resulting from apoptotic cell death.
Funding history · 1 round · — total
2021-01
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
pharmaceuticalsneurologybiochemical-compoundscell-therapytherapeuticsbiotechnology